Retinoid X receptors: X-ploring their (patho)physiological functions

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• Retinoid X receptor (RXR) is a ligand-activated transcription factor crucial for metazoan life.
• RXR acts as a heterodimerization partner for various nuclear receptors, positioning it at the convergence of multiple biological pathways.
• The precise endogenous ligand requirements for RXR function remain an area of active investigation, contributing to its enigmatic nature.

Purpose of the Study:

• To provide a comprehensive review of Retinoid X receptor (RXR) biology.
• To elucidate RXR's evolutionary context, structural characteristics, and ligand interactions.
• To discuss RXR's regulatory roles in development, metabolism, myeloid differentiation, and apoptosis, and assess its therapeutic potential.

Main Methods:

• Literature review synthesizing existing research on RXR.
• Analysis of data from knockout animal studies to understand developmental roles.
• Examination of pharmacological studies investigating RXR's metabolic functions in disease models.

Main Results:

• RXR plays critical roles in embryonic development, as evidenced by knockout studies.
• Pharmacological studies demonstrate RXR's involvement in metabolic diseases like diabetes and atherosclerosis.
• RXR influences myeloid differentiation and apoptosis, with implications for cancer therapy.

Conclusions:

• RXR is a central regulator of diverse biological processes, from development to disease.
• Understanding RXR's complex biology and ligand interactions is essential for therapeutic applications.
• RXR presents a promising, albeit complex, target for pharmacological intervention in various diseases.